Publicação
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
| Resumo: | SARS-CoV-2 has emerged as a human pathogen, causing clinical signs, from fever to pneumonia-COVID-19-but may remain mild or asymptomatic. To understand the continuing spread of the virus, to detect those who are and were infected, and to follow the immune response longitudinally, reliable and robust assays for SARS-CoV-2 detection and immunological monitoring are needed. We quantified IgM, IgG, and IgA antibodies recognizing the SARS-CoV-2 receptor-binding domain (RBD) or the Spike (S) protein over a period of 6 months following COVID-19 onset. We report the detailed setup to monitor the humoral immune response from over 300 COVID-19 hospital patients and healthcare workers, 2500 University staff, and 198 post-COVID-19 volunteers. Anti-SARS-CoV-2 antibody responses follow a classic pattern with a rapid increase within the first three weeks after symptoms. Although titres reduce subsequently, the ability to detect anti-SARS-CoV-2 IgG antibodies remained robust with confirmed neutralization activity for up to 6 months in a large proportion of previously virus-positive screened subjects. Our work provides detailed information for the assays used, facilitating further and longitudinal analysis of protective immunity to SARS-CoV-2. Importantly, it highlights a continued level of circulating neutralising antibodies in most people with confirmed SARS-CoV-2. |
|---|---|
| Autores principais: | personFigueiredo-Campos, Patricia |
| Outros Autores: | personBlankenhaus, Birte; personMota, Catarina; Gomes, Andreia; Serrano, Marta; personAriotti, Silvia; Costa, Catarina; personNunes-Cabaço, Helena; personMendes, António M.; personGaspar, Pedro; Pereira‐Santos, M. Conceição; Rodrigues, Fabiana; Condeço, Jorge; Escoval, M. Antonia; Santos, Matilde; personRamirez, Mário; personCristino, José Melo; personSimas, J Pedro; Vasconcelos, Eugenia; Afonso, Ângela; personVeldhoen, Marc |
| Assunto: | COVID-19 SARS-CoV-2 Seroprevalence Neutralizing antibodies |
| Ano: | 2020 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório da Universidade de Lisboa |
Registos relacionados
article Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset
por: Figueiredo-Campos, Patrícia
Publicado em: (2020)
por: Figueiredo-Campos, Patrícia
Publicado em: (2020)
article Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant
por: Villas-Boas, Lucy Santos
Publicado em: (2022)
por: Villas-Boas, Lucy Santos
Publicado em: (2022)
article The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study
por: Meireles, P
Publicado em: (2022)
por: Meireles, P
Publicado em: (2022)
category Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated
por: Sérgio, Sarah Aparecida Rodrigues
Publicado em: (2022)
por: Sérgio, Sarah Aparecida Rodrigues
Publicado em: (2022)
article Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis
por: Figueiredo, Gerusa Maria
Publicado em: (2023)
por: Figueiredo, Gerusa Maria
Publicado em: (2023)
article Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study
por: Vale, Nayara Moya Rios do
Publicado em: (2022)
por: Vale, Nayara Moya Rios do
Publicado em: (2022)
article Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal
por: e Silva, Daniela Fonseca
Publicado em: (2021)
por: e Silva, Daniela Fonseca
Publicado em: (2021)
category Standardization of a plaque reduction test and evaluation of neutralizing antibodies responses to SARS-CoV-2
por: Horbach, Ingrid
Publicado em: (2021)
por: Horbach, Ingrid
Publicado em: (2021)
article IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Siqueira, Lorena O. Fernandes
Publicado em: (2022)
por: Siqueira, Lorena O. Fernandes
Publicado em: (2022)
article Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil
por: Dias, Helver Gonçalves
Publicado em: (2021)
por: Dias, Helver Gonçalves
Publicado em: (2021)
article SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
por: Lalwani, Pritesh
Publicado em: (2022)
por: Lalwani, Pritesh
Publicado em: (2022)
article Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil
por: Tess,Beatriz Helena
Publicado em: (2021)
por: Tess,Beatriz Helena
Publicado em: (2021)
article Seroprevalence of SARS-CoV-2 among health care personnel in Portugal
por: de Carvalho, Álvaro
Publicado em: (2021)
por: de Carvalho, Álvaro
Publicado em: (2021)
article Seroprevalence of SARS-CoV-2 in client-owned cats from Portugal
por: Oliveira, Andreia
Publicado em: (2022)
por: Oliveira, Andreia
Publicado em: (2022)
article Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal
por: Oliveira, Andreia
Publicado em: (2022)
por: Oliveira, Andreia
Publicado em: (2022)
article Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal
por: Oliveira, A
Publicado em: (2022)
por: Oliveira, A
Publicado em: (2022)
school Soroprevalência de anticorpos anti-SARS-CoV-2 em doadores de sangue em diferentes populações do Estado de São Paulo e correlação com aspectos sócio demográficos
por: Vale, Nayara Moya Rios do [UNIFESP]
Publicado em: (2023)
por: Vale, Nayara Moya Rios do [UNIFESP]
Publicado em: (2023)
article Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020
por: Kamioka, Gabriela Akemi
Publicado em: (2023)
por: Kamioka, Gabriela Akemi
Publicado em: (2023)
category Neutralizing antibodies and igg avidity against SARS-CoV-2 variants
por: Dias, Brenda de Moura
Publicado em: (2023)
por: Dias, Brenda de Moura
Publicado em: (2023)
category A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus
por: Pscheidt, Veridiane Maria
Publicado em: (2023)
por: Pscheidt, Veridiane Maria
Publicado em: (2023)
article Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil
por: Oliveira, Luanda Mara da Silva
Publicado em: (2020)
por: Oliveira, Luanda Mara da Silva
Publicado em: (2020)
category Development of monoclonal antibodies targeting SARS-CoV-2 Spike and Nucleocapsid proteins
por: Carvalho, Milena Mouta Verdan França
Publicado em: (2021)
por: Carvalho, Milena Mouta Verdan França
Publicado em: (2021)
article SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
por: Dejnirattisai, Wanwisa
Publicado em: (2022)
por: Dejnirattisai, Wanwisa
Publicado em: (2022)
category Development of anti-SARS-CoV-2 specific scFv antibody library from convalescent plasma of COVID-19 recovered patients using phage display technology
por: Ahmed, Kafil
Publicado em: (2021)
por: Ahmed, Kafil
Publicado em: (2021)
category Production of a monoclonal antibody against SARS-CoV-2 and determination of viral neutralization capacity
por: Almeida, Nathalie Bonatti Franco
Publicado em: (2021)
por: Almeida, Nathalie Bonatti Franco
Publicado em: (2021)
school Characterization of the humoral response of domestic cats naturally infected with SARS-CoV-2
por: Henriques, Mafalda Alexandra Pereira
Publicado em: (2022)
por: Henriques, Mafalda Alexandra Pereira
Publicado em: (2022)
article Plasmodium infection is associated with cross‑reactive antibodies to carbohydrate epitopes on the SARS‑CoV‑2 Spike protein
por: Lapidus, Sarah
Publicado em: (2023)
por: Lapidus, Sarah
Publicado em: (2023)
category Study of seroprevalence in health personnel: Relation of vaccination with the presence of previous infection by SARS-COV-2 in the context of the national vaccination campaign for coronavirus after the first dose of the Gam-COVID-VAc vaccine (Sputnik -V).
por: Tortosa, Fernando
Publicado em: (2021)
por: Tortosa, Fernando
Publicado em: (2021)
article SARS-CoV-2 seroprevalence and social inequalities in different subgroups of healthcare workers in Rio de Janeiro, Brazil
por: Correia, Roberta Fernandes
Publicado em: (2022)
por: Correia, Roberta Fernandes
Publicado em: (2022)
article SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines
por: Torres,Thiago S.
Publicado em: (2021)
por: Torres,Thiago S.
Publicado em: (2021)
article SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines
por: Torres, Thiago S.
Publicado em: (2021)
por: Torres, Thiago S.
Publicado em: (2021)
article Harmonization of IgG antibody values against the SARS-CoV-2 Spike protein
por: Saraiva, Ana Leonor
Publicado em: (2026)
por: Saraiva, Ana Leonor
Publicado em: (2026)
groups SARS-CoV-2 Seroprevalence among hospital healthcare workers in comparison with the general population, 2021-2022
por: Gaio, Vânia
Publicado em: (2025)
por: Gaio, Vânia
Publicado em: (2025)
article Humoral immune response of SARS-CoV-2-infected patients with cancer: influencing factors and mechanisms
por: Esperança Martins, Miguel
Publicado em: (2021)
por: Esperança Martins, Miguel
Publicado em: (2021)
article Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
por: Miyaji, Karina Takesaki
Publicado em: (2017)
por: Miyaji, Karina Takesaki
Publicado em: (2017)
description A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum
por: Abidi, Syed Hani
Publicado em: (2021)
por: Abidi, Syed Hani
Publicado em: (2021)
school Novel Avian IgY antibody formulations to combat SARS-CoV-2
por: Pires, Tiago Maria Santos de Ochôa e Azevedo
Publicado em: (2025)
por: Pires, Tiago Maria Santos de Ochôa e Azevedo
Publicado em: (2025)
article Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal
por: Oliveira, Andreia
Publicado em: (2022)
por: Oliveira, Andreia
Publicado em: (2022)
article SARS-CoV-2 antibody prevalence in the portuguese municipality of Vila Nova de Gaia after the first wave of the pandemic
por: De Carvalho, Álvaro
Publicado em: (2022)
por: De Carvalho, Álvaro
Publicado em: (2022)
article Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2
por: de Silva, PG
Publicado em: (2021)
por: de Silva, PG
Publicado em: (2021)
Registos relacionados
-
article Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset
por: Figueiredo-Campos, Patrícia
Publicado em: (2020) -
article Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant
por: Villas-Boas, Lucy Santos
Publicado em: (2022) -
article The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study
por: Meireles, P
Publicado em: (2022) -
category Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated
por: Sérgio, Sarah Aparecida Rodrigues
Publicado em: (2022) -
article Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis
por: Figueiredo, Gerusa Maria
Publicado em: (2023)